| DA2 | 表記: | NG,NG-DIMETHYL-L-ARGININE | 組成式: | C8 H18 N4 O2 | SMILES: | CN(C)C(/NCCCC(N)C(=O)O)=N | InChi: | InChI=1S/C8H18N4O2/c1-12(2)8(10)11-5-3-4-6(9)7(13)14/h6H,3-5,9H2,1-2H3,(H2,10,11)(H,13,14)/t6-/m0/s1 | 別名: | ADMA | 定義日: | 1999-07-27 | 最終更新日: | 2023-11-03 | 識別子(ID): | N~5~-(N,N-dimethylcarbamimidoyl)-L-ornithine |
|
| DAH | 表記: | 3,4-DIHYDROXYPHENYLALANINE | 組成式: | C9 H11 N O4 | SMILES: | O=C(O)C(N)Cc1cc(O)c(O)cc1 | InChi: | InChI=1S/C9H11NO4/c10-6(9(13)14)3-5-1-2-7(11)8(12)4-5/h1-2,4,6,11-12H,3,10H2,(H,13,14)/t6-/m0/s1 | 別名: | L-DOPA | 定義日: | 1999-07-08 | 最終更新日: | 2023-11-03 | 識別子(ID): | 3-hydroxy-L-tyrosine |
|
| DBY | 表記: | 3,5 DIBROMOTYROSINE | 組成式: | C9 H9 Br2 N O3 | SMILES: | Brc1cc(cc(Br)c1O)CC(C(=O)O)N | InChi: | InChI=1S/C9H9Br2NO3/c10-5-1-4(2-6(11)8(5)13)3-7(12)9(14)15/h1-2,7,13H,3,12H2,(H,14,15)/t7-/m0/s1 | 定義日: | 1999-07-08 | 最終更新日: | 2023-11-03 | 識別子(ID): | 3,5-dibromo-L-tyrosine |
|
| DBZ | 表記: | 3-(BENZOYLAMINO)-L-ALANINE | 組成式: | C10 H12 N2 O3 | SMILES: | O=C(NCC(C(=O)O)N)c1ccccc1 | InChi: | InChI=1S/C10H12N2O3/c11-8(10(14)15)6-12-9(13)7-4-2-1-3-5-7/h1-5,8H,6,11H2,(H,12,13)(H,14,15)/t8-/m0/s1 | 定義日: | 2004-03-14 | 最終更新日: | 2023-11-03 | 識別子(ID): | 3-[(phenylcarbonyl)amino]-L-alanine |
|
| DC0 | 表記: | N-[(2S)-2-amino-4-methylpentyl]-L-phenylalanine | 組成式: | C15 H24 N2 O2 | SMILES: | O=C(O)C(NCC(N)CC(C)C)Cc1ccccc1 | InChi: | InChI=1S/C15H24N2O2/c1-11(2)8-13(16)10-17-14(15(18)19)9-12-6-4-3-5-7-12/h3-7,11,13-14,17H,8-10,16H2,1-2H3,(H,18,19)/t13-,14-/m0/s1 | 定義日: | 2010-10-09 | 最終更新日: | 2023-11-03 | 識別子(ID): | N-[(2S)-2-amino-4-methylpentyl]-L-phenylalanine |
|
| DDE | 表記: | {3-[4-(2-AMINO-2-CARBOXY-ETHYL)-1H-IMIDAZOL-2-YL]-1-CARBAMOYL-PROPYL}-TRIMETHYL-AMMONIUM | 組成式: | C13 H24 N5 O3 | SMILES: | O=C(O)C(N)Cc1nc(nc1)CCC(C(=O)N)[N+](C)(C)C | InChi: | InChI=1S/C13H23N5O3/c1-18(2,3)10(12(15)19)4-5-11-16-7-8(17-11)6-9(14)13(20)21/h7,9-10H,4-6,14H2,1-3H3,(H3-,15,16,17,19,20,21)/p+1/t9-,10+/m0/s1 | 別名: | DIPHTHAMIDE | 定義日: | 2004-07-29 | 最終更新日: | 2023-11-03 | 識別子(ID): | (2R)-1-amino-4-{4-[(2S)-2-amino-2-carboxyethyl]-1H-imidazol-2-yl}-N,N,N-trimethyl-1-oxobutan-2-aminium |
|
| DFF | 表記: | 4-benzoyl-D-phenylalanine | 組成式: | C16 H15 N O3 | SMILES: | O=C(O)C(N)Cc1ccc(cc1)C(=O)c2ccccc2 | InChi: | InChI=1S/C16H15NO3/c17-14(16(19)20)10-11-6-8-13(9-7-11)15(18)12-4-2-1-3-5-12/h1-9,14H,10,17H2,(H,19,20)/t14-/m1/s1 | 定義日: | 2013-12-24 | 最終更新日: | 2023-11-03 | 公開日: | 2014-05-21 | 識別子(ID): | 4-benzoyl-D-phenylalanine |
|
| DFI | 表記: | 2,2-DIFLUOROSTATINE | 組成式: | C8 H15 F2 N O3 | SMILES: | FC(F)(C(=O)O)C(O)C(N)CC(C)C | InChi: | InChI=1S/C8H15F2NO3/c1-4(2)3-5(11)6(12)8(9,10)7(13)14/h4-6,12H,3,11H2,1-2H3,(H,13,14)/t5-,6+/m0/s1 | 定義日: | 1999-07-08 | 最終更新日: | 2023-11-03 | 識別子(ID): | (3R,4S)-4-amino-2,2-difluoro-3-hydroxy-6-methylheptanoic acid |
|
| DFO | 表記: | 2,2-DIFLUORO-3-HYDROSTATINE | 組成式: | C8 H15 F2 N O4 | SMILES: | FC(F)(C(=O)O)C(O)(O)C(N)CC(C)C | InChi: | InChI=1S/C8H15F2NO4/c1-4(2)3-5(11)8(14,15)7(9,10)6(12)13/h4-5,14-15H,3,11H2,1-2H3,(H,12,13)/t5-/m0/s1 | 定義日: | 1999-07-08 | 最終更新日: | 2023-11-03 | 識別子(ID): | (4S)-4-amino-2,2-difluoro-3,3-dihydroxy-6-methylheptanoic acid |
|
| APN | 表記: | 2-AMINOETHYLGLYCINE-CARBONYLMETHYLENE-ADENINE | 組成式: | C11 H16 N7 O3 | SMILES: | O=C(O)CN(C(=O)Cn1c2ncnc(c2nc1)N)CC[NH3+] | InChi: | InChI=1S/C11H15N7O3/c12-1-2-17(4-8(20)21)7(19)3-18-6-16-9-10(13)14-5-15-11(9)18/h5-6H,1-4,12H2,(H,20,21)(H2,13,14,15)/p+1 | 定義日: | 1999-07-08 | 最終更新日: | 2023-11-03 | 識別子(ID): | 2-{[(6-amino-9H-purin-9-yl)acetyl](carboxymethyl)amino}ethanaminium |
|
| AR0 | 表記: | 4-amino-1-{[amino(iminio)methyl]amino}-6-[4-(carboxymethyl)pyridinium-1-yl]-1,2,3,4,6-pentadeoxy-D-erythro-hexitol | 組成式: | C14 H25 N5 O3 | SMILES: | O=C(O)Cc1cc[n+](cc1)CC(O)C(N)CCCNC(=[NH2+])N | InChi: | InChI=1S/C14H23N5O3/c15-11(2-1-5-18-14(16)17)12(20)9-19-6-3-10(4-7-19)8-13(21)22/h3-4,6-7,11-12,20H,1-2,5,8-9,15H2,(H4-,16,17,18,21,22)/p+2/t11-,12+/m0/s1 | 定義日: | 2010-09-17 | 最終更新日: | 2023-11-03 | 識別子(ID): | 4-amino-1-{[amino(iminio)methyl]amino}-6-[4-(carboxymethyl)pyridinium-1-yl]-1,2,3,4,6-pentadeoxy-D-erythro-hexitol |
|
| ASL | 表記: | ASPARTIC ACID-4-CARBOXYETHYL ESTER | 組成式: | C7 H11 N O6 | SMILES: | O=C(OC(C(=O)O)C)CC(C(=O)O)N | InChi: | InChI=1S/C7H11NO6/c1-3(6(10)11)14-5(9)2-4(8)7(12)13/h3-4H,2,8H2,1H3,(H,10,11)(H,12,13) | 定義日: | 1999-09-09 | 最終更新日: | 2023-11-03 | 識別子(ID): | 2-amino-4-(1-carboxyethoxy)-4-oxobutanoic acid (non-preferred name) |
|
| AUX | 表記: | 4-METHYL-4-[8-QUINOLINIUM-4-ENE]-4,N-METHYL-THREONINE | 組成式: | C21 H29 N2 O3 | SMILES: | CN[CH]([CH](O)[CH](C)CC=CCCC[n+]1cccc2ccccc12)C(O)=O | InChi: | InChI=1S/C21H28N2O3/c1-16(20(24)19(22-2)21(25)26)10-5-3-4-8-14-23-15-9-12-17-11-6-7-13-18(17)23/h3,5-7,9,11-13,15-16,19-20,22,24H,4,8,10,14H2,1-2H3/p+1/b5-3+/t16-,19+,20-/m1/s1 | 定義日: | 2015-05-14 | 最終更新日: | 2023-11-03 | 公開日: | 2015-12-29 | 識別子(ID): | (E,2S,3R,4R)-4-methyl-2-(methylamino)-3-oxidanyl-10-quinolin-1-ium-1-yl-dec-6-enoic acid |
|
| AY0 | 表記: | (1R,2R,3S)-2-(methylcarbamoyl)-3-[4-(phosphonooxy)phenyl]cyclopropanecarboxylic acid | 組成式: | C12 H14 N O7 P | SMILES: | O=C(NC)C2C(c1ccc(OP(=O)(O)O)cc1)C2C(=O)O | InChi: | InChI=1S/C12H14NO7P/c1-13-11(14)9-8(10(9)12(15)16)6-2-4-7(5-3-6)20-21(17,18)19/h2-5,8-10H,1H3,(H,13,14)(H,15,16)(H2,17,18,19)/t8-,9+,10+/m0/s1 | 定義日: | 2010-10-09 | 最終更新日: | 2023-11-03 | 識別子(ID): | (1R,2R,3S)-2-(methylcarbamoyl)-3-[4-(phosphonooxy)phenyl]cyclopropanecarboxylic acid |
|
| B2C | 表記: | {(4Z)-2-[(1R,2R)-1-amino-2-hydroxypropyl]-4-[(3-bromo-4-hydroxyphenyl)methylidene]-5-oxo-4,5-dihydro-1H-imidazol-1-yl}acetic acid | 組成式: | C15 H16 Br N3 O5 | SMILES: | C(O)(C)C(C2=NC(=[C@H]c1cc(Br)c(cc1)O)C(N2CC(O)=O)=O)N | InChi: | InChI=1S/C15H16BrN3O5/c1-7(20)13(17)14-18-10(15(24)19(14)6-12(22)23)5-8-2-3-11(21)9(16)4-8/h2-5,7,13,20-21H,6,17H2,1H3,(H,22,23)/b10-5-/t7-,13+/m1/s1 | 定義日: | 2019-04-02 | 最終更新日: | 2023-11-03 | 公開日: | 2020-04-08 | 識別子(ID): | {(4Z)-2-[(1R,2R)-1-amino-2-hydroxypropyl]-4-[(3-bromo-4-hydroxyphenyl)methylidene]-5-oxo-4,5-dihydro-1H-imidazol-1-yl}acetic acid |
|
| B2H | 表記: | Chromophore (Thr, Trp, Gly) | 組成式: | C17 H20 N4 O4 | SMILES: | C[CH](O)[CH](N)c1nc(Cc2c[nH]c3ccccc23)c(O)n1CC(O)=O | InChi: | InChI=1S/C17H20N4O4/c1-9(22)15(18)16-20-13(17(25)21(16)8-14(23)24)6-10-7-19-12-5-3-2-4-11(10)12/h2-5,7,9,15,19,22,25H,6,8,18H2,1H3,(H,23,24)/t9-,15+/m1/s1 | 定義日: | 2017-09-06 | 最終更新日: | 2023-11-03 | 公開日: | 2017-11-29 | 識別子(ID): | 2-[2-[(1~{R},2~{R})-1-azanyl-2-oxidanyl-propyl]-4-(1~{H}-indol-3-ylmethyl)-5-oxidanyl-imidazol-1-yl]ethanoic acid |
|
| F7P | 表記: | 1-[(3R)-3-hydroxy-2-methylbutan-2-yl]-L-tryptophan | 組成式: | C16 H22 N2 O3 | SMILES: | C(C(N)C(O)=O)c2c1ccccc1n(c2)C(C(C)O)(C)C | InChi: | InChI=1S/C16H22N2O3/c1-10(19)16(2,3)18-9-11(8-13(17)15(20)21)12-6-4-5-7-14(12)18/h4-7,9-10,13,19H,8,17H2,1-3H3,(H,20,21)/t10-,13+/m1/s1 | 定義日: | 2018-03-09 | 最終更新日: | 2023-11-03 | 公開日: | 2019-06-05 | 識別子(ID): | 1-[(3R)-3-hydroxy-2-methylbutan-2-yl]-L-tryptophan |
|
| F7W | 表記: | 7-Fluorotryptophan | 組成式: | C11 H11 F N2 O2 | SMILES: | N[CH](Cc1c[nH]c2c(F)cccc12)C(O)=O | InChi: | InChI=1S/C11H11FN2O2/c12-8-3-1-2-7-6(5-14-10(7)8)4-9(13)11(15)16/h1-3,5,9,14H,4,13H2,(H,15,16)/t9-/m0/s1 | 定義日: | 2017-06-09 | 最終更新日: | 2023-11-03 | 公開日: | 2018-06-06 | 識別子(ID): | (2~{S})-2-azanyl-3-(7-fluoranyl-1~{H}-indol-3-yl)propanoic acid |
|
| F93 | 表記: | (2R,3S)-2-azanyl-3-(3-chloranyl-4-oxidanyl-phenyl)-3-oxidanyl-propanoic acid | 組成式: | C9 H10 Cl N O4 | SMILES: | N[CH]([CH](O)c1ccc(O)c(Cl)c1)C(O)=O | InChi: | InChI=1S/C9H10ClNO4/c10-5-3-4(1-2-6(5)12)8(13)7(11)9(14)15/h1-3,7-8,12-13H,11H2,(H,14,15)/t7-,8+/m1/s1 | 定義日: | 2020-04-16 | 最終更新日: | 2023-11-03 | 公開日: | 2020-11-18 | 識別子(ID): | (2~{R},3~{S})-2-azanyl-3-(3-chloranyl-4-oxidanyl-phenyl)-3-oxidanyl-propanoic acid |
|
| FC0 | 表記: | N-CARBOXY-L-PHENYLALANINE | 組成式: | C10 H11 N O4 | SMILES: | O=C(O)C(NC(=O)O)Cc1ccccc1 | InChi: | InChI=1S/C10H11NO4/c12-9(13)8(11-10(14)15)6-7-4-2-1-3-5-7/h1-5,8,11H,6H2,(H,12,13)(H,14,15)/t8-/m0/s1 | 定義日: | 2010-05-11 | 最終更新日: | 2023-11-03 | 識別子(ID): | N-carboxy-L-phenylalanine |
|
| FF9 | 表記: | (2S)-2-azanyl-6-[(E)-(1-oxidanyl-1-oxidanylidene-butan-2-ylidene)amino]hexanoic acid | 組成式: | C10 H18 N2 O4 | SMILES: | CCC(=NCCCC[CH](N)C(O)=O)C(O)=O | InChi: | InChI=1S/C10H18N2O4/c1-2-8(10(15)16)12-6-4-3-5-7(11)9(13)14/h7H,2-6,11H2,1H3,(H,13,14)(H,15,16)/b12-8+/t7-/m0/s1 | 定義日: | 2020-05-08 | 最終更新日: | 2023-11-03 | 公開日: | 2020-08-05 | 識別子(ID): | (2~{S})-2-azanyl-6-[(~{E})-(1-oxidanyl-1-oxidanylidene-butan-2-ylidene)amino]hexanoic acid |
|
| DI7 | 表記: | 2,6-dimethyl-L-tyrosine | 組成式: | C11 H15 N O3 | SMILES: | O=C(O)C(N)Cc1c(cc(O)cc1C)C | InChi: | InChI=1S/C11H15NO3/c1-6-3-8(13)4-7(2)9(6)5-10(12)11(14)15/h3-4,10,13H,5,12H2,1-2H3,(H,14,15)/t10-/m0/s1 | 定義日: | 2014-12-10 | 最終更新日: | 2023-11-03 | 公開日: | 2015-01-14 | 識別子(ID): | 2,6-dimethyl-L-tyrosine |
|
| DJD | 表記: | 4-(6-methyl-1,2,4,5-tetrazin-3-yl)-L-phenylalanine | 組成式: | C12 H13 N5 O2 | SMILES: | NC(Cc1ccc(cc1)c2nnc(C)nn2)C(O)=O | InChi: | InChI=1S/C12H13N5O2/c1-7-14-16-11(17-15-7)9-4-2-8(3-5-9)6-10(13)12(18)19/h2-5,10H,6,13H2,1H3,(H,18,19)/t10-/m0/s1 | 定義日: | 2017-10-26 | 最終更新日: | 2023-11-03 | 公開日: | 2019-10-02 | 識別子(ID): | 4-(6-methyl-1,2,4,5-tetrazin-3-yl)-L-phenylalanine |
|
| DM0 | 表記: | N~2~,N~2~,N~6~,N~6~-tetramethyl-L-lysine | 組成式: | C10 H22 N2 O2 | SMILES: | O=C(O)C(N(C)C)CCCCN(C)C | InChi: | InChI=1S/C10H22N2O2/c1-11(2)8-6-5-7-9(10(13)14)12(3)4/h9H,5-8H2,1-4H3,(H,13,14)/t9-/m0/s1 | 定義日: | 2008-03-25 | 最終更新日: | 2023-11-03 | 識別子(ID): | N~2~,N~2~,N~6~,N~6~-tetramethyl-L-lysine |
|
| DMT | 表記: | 3-HYDROXY-4,4-DIMETHYL-2-(METHYLAMINO)-6-OCTENOIC ACID | 組成式: | C11 H21 N O3 | SMILES: | O=C(O)C(NC)C(O)C(C/C=C/C)(C)C | InChi: | InChI=1S/C11H21NO3/c1-5-6-7-11(2,3)9(13)8(12-4)10(14)15/h5-6,8-9,12-13H,7H2,1-4H3,(H,14,15)/b6-5+/t8-,9-/m0/s1 | 定義日: | 1999-07-08 | 最終更新日: | 2023-11-03 | 識別子(ID): | 4-[(2E)-but-2-en-1-yl]-2,4,5-trideoxy-4-methyl-2-(methylamino)-D-arabinonic acid |
|